NIH-funded research Sbir 1 grant

Creating a human brain model to study and treat Temporal Lobe Epilepsy

Official title: Development and Validation of a CNS Organoid Model of Temporal Lobe Epilepsy for Drug Discovery

Funded at Stem Pharm, INC. · NIH-11008599 · Data updated 2026-11-12

This study is creating a mini version of the human brain to learn more about Temporal Lobe Epilepsy and find better treatments for people who struggle with seizures that don’t respond well to current medications.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionStem Pharm, INC.
NIH-funded
Lab location1 site (Madison, United States)
Project startSeptember 15, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$499,953
NIH project number1R43NS139845-01
Project IDNIH-11008599 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 21 and older who suffer from Temporal Lobe Epilepsy and have not responded well to existing anti-seizure medications.

Less likely to help

Patients with other forms of epilepsy or those who are not experiencing drug-resistant seizures may not benefit from this research.

What this research studies

This research focuses on developing a human brain organoid model to better understand and treat Temporal Lobe Epilepsy (TLE), a condition that affects many individuals and is often resistant to current medications. By using human stem cell-derived neural organoids that include microglia, the study aims to replicate the neuroinflammation associated with TLE more accurately than traditional animal models. This innovative approach allows for the screening of new drug compounds that target neuroinflammation, potentially leading to more effective treatments for patients suffering from chronic seizures.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve the management of Temporal Lobe Epilepsy and reduce the frequency of seizures in affected patients.

How similar studies have gone: While the approach of using human organoids for drug discovery is gaining traction, this specific application for Temporal Lobe Epilepsy is relatively novel and has not been extensively tested in prior studies.

Where this research is happening

  • Stem Pharm, INC.
    Madison, United States
    Active

Researchers

  • Principal investigator: Lebakken, Connie S — Stem Pharm, INC.
  • Study coordinator: Lebakken, Connie S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.